U.S. Other Utilities Stock News

NasdaqGS:ACGL
NasdaqGS:ACGLInsurance

How Strong Q1 2026 Margins and Buybacks At Arch Capital Group (ACGL) Have Changed Its Investment Story

Arch Capital Group Ltd. has reported past first-quarter 2026 results with revenue of US$4,521 million, net income of US$1.05 billion, and diluted EPS from continuing operations of US$2.88, alongside US$783 million of share repurchases representing 2.32% of its shares. Despite slightly softer revenue than a year earlier and some variance versus analyst forecasts, Arch’s stronger underwriting margins, lower catastrophe loss burden and sizeable buyback activity highlighted how its operating...
NYSE:KMI
NYSE:KMIOil and Gas

Kinder Morgan (KMI) Valuation Check After Earnings Beat Dividend Hike And Energy Market Volatility

Why Kinder Morgan’s recent quarter is back in focus Kinder Morgan (KMI) is back on many watchlists after a first quarter that topped analyst earnings expectations, combined with a dividend increase and reinforced by volatile global energy markets linked to the Iran conflict. See our latest analysis for Kinder Morgan. Despite a recent 1 day share price return of around a 1% decline, Kinder Morgan’s 90 day share price return of 9.86% and 1 year total shareholder return of 25.11% suggest...
NYSE:PRKS
NYSE:PRKSHospitality

Is It Time To Reconsider United Parks & Resorts (PRKS) After A 23% One Year Decline?

If you are wondering whether United Parks & Resorts at around US$35.27 is priced for a rebound or still has work to do, the numbers offer some useful clues about value. The stock has returned 4.3% over the last week and 4.8% over the past month, although year to date it is down 2.6% and the 1 year return sits at a 23.2% decline, with 3 and 5 year returns of 36.1% and 34.3% declines respectively. Recent attention on United Parks & Resorts has focused on how the share price performance...
NasdaqGS:FTRE
NasdaqGS:FTRELife Sciences

Do Fortrea Holdings' (FTRE) Shrinking Sales Reveal Deeper Strains In Its Growth Strategy?

Fortrea Holdings Inc., a contract research organization spun off from Labcorp in 2023, has recently reported that its sales have declined by an average 2.9% each year over the past four years, alongside returns on capital that remain below zero. This combination of contracting revenue and ineffective investment decisions suggests earlier profit pools are shrinking and raises fresh questions about the company’s ability to execute its growth plans. Against this backdrop of multi‑year sales...
NasdaqGS:STRA
NasdaqGS:STRAConsumer Services

Why Strategic Education (STRA) Is Up 6.4% After Q1 Buybacks, Dividend And Soft Enrollment News

In the first quarter of 2026, Strategic Education, Inc. reported modest year-on-year growth in sales and earnings, completed a long-running US$955.15 million share repurchase program, and declared a regular quarterly dividend of US$0.60 per share, all of which were announced on April 23, 2026. At the same time, the company faced pressure from softer enrollment and regulatory headwinds, while large passive investors like Vanguard disclosed multi-million share stakes that underline broad...
NYSE:SPXC
NYSE:SPXCMachinery

SPX Technologies (SPXC) Is Down 6.6% After Raising 2026 Revenue Guidance on Data Center HVAC Demand

In late April 2026, SPX Technologies reported first-quarter 2026 results showing year-on-year growth in sales to US$566.8 million and net income to US$59.9 million, and raised its full-year 2026 revenue guidance to a range of US$2.575 billion to US$2.645 billion. The upgraded outlook was underpinned by strong contributions from the HVAC and Detection & Measurement segments, particularly increased demand for data center cooling solutions and benefits from recent acquisitions. Given this...
NYSE:DQ
NYSE:DQSemiconductor

Is Daqo New Energy (DQ) Pricing Look Attractive After Recent Share Price Slide

If you are wondering whether Daqo New Energy's current share price reflects its true worth, it helps to start with how the market has been treating the stock lately. The shares last closed at US$19.14, with returns of a 16.7% decline over 7 days, a 9.3% decline over 30 days, and a 35.5% decline year to date, contrasted with a 48.5% gain over the past year and larger declines of 57.2% and 74.4% over 3 and 5 years. These moves have played out against a backdrop of ongoing interest in the solar...
NYSE:GD
NYSE:GDAerospace & Defense

Why General Dynamics (GD) Is Up 10.4% After Raising 2026 EPS Outlook On Record Defense Backlog

General Dynamics Corporation has already reported first-quarter 2026 results, posting revenue of US$13.48 billion and net income of US$1.13 billion, with diluted EPS from continuing operations of US$4.10, all higher than a year earlier. The company paired this earnings beat with a raised full-year EPS outlook and record backlog underpinned by strong order intake and heightened global defense demand. We’ll now examine how this combination of raised earnings guidance and record backlog...
NYSE:DAL
NYSE:DALAirlines

A Look At Delta Air Lines (DAL) Valuation After A Strong 1 Year Run

Valuation snapshot after a strong 1 year run Delta Air Lines (DAL) has drawn attention after a 1 year total return of 58%, leaving some investors rechecking what they are paying for the stock versus recent performance and fundamentals. See our latest analysis for Delta Air Lines. The recent 1 day share price return of 1.46% and 1 month share price return of 3.33% sit alongside a 1 year total shareholder return of 57.98%. This indicates that momentum has been building over both shorter and...
NasdaqGM:RUM
NasdaqGM:RUMInteractive Media and Services

Assessing Rumble (RUM) Valuation After The OpenClaw AI And Crypto Integration Launch

Why Rumble’s OpenClaw launch matters for RUM stock watchers Rumble (RUM) has drawn fresh attention after launching its OpenClaw Starter package on Rumble Cloud, a hosted setup that lets users run personal AI agents with pre-integrated crypto payments tools. See our latest analysis for Rumble. At a share price of $7.34, Rumble has seen strong short term momentum, with a 47.39% 30 day share price return and 29.00% 90 day share price return, while the 1 year total shareholder return of 8.93%...
NasdaqGS:EBAY
NasdaqGS:EBAYMultiline Retail

Is It Too Late To Consider eBay (EBAY) After A 54% One Year Surge?

If you are wondering whether eBay at around US$104 per share still offers value, you are not alone. The recent share price performance raises fair questions about what is already priced in. The stock has returned 6.3% over the last 7 days, 10.5% over the last 30 days, 19.5% year to date and 53.8% over the past year, with longer term returns of 141.0% over 3 years and 90.0% over 5 years. Recent news flow around eBay has continued to focus on its position as a major online marketplace,...
NYSE:SGHC
NYSE:SGHCHospitality

Formula 1 Betting Deal and Analyst Upgrades Could Be A Game Changer For Super Group (SGHC)

Super Group (SGHC) recently entered into a partnership to become Formula 1’s first official betting operator, while analysts had earlier shifted their brokerage recommendations and Zacks Rank ahead of its May 11, 2026 earnings report. This combination of a high-profile sports betting partnership and elevated earnings expectations has reshaped how investors interpret Super Group’s growth potential and business momentum. We’ll now explore how the new Formula 1 betting partnership affects...
NasdaqGS:LASR
NasdaqGS:LASRElectronic

Is It Too Late To Consider nLIGHT (LASR) After Its Surging Share Price This Year?

For readers wondering whether nLIGHT's share price still reflects fair value after a major run-up, this article breaks down what the current price could imply about the business and its risks. Over the past week the stock has declined 6.3%, but it shows an 18.1% return over 30 days and an 85.0% return year to date, with the 1-year move sitting at roughly 7x. Recent coverage has focused on nLIGHT's position in the broader tech sector and how sentiment around high-growth, higher-risk names has...
NasdaqGM:NVTS
NasdaqGM:NVTSSemiconductor

Did Navitas’s New AI Power Board and Fischer Hire Just Shift Navitas Semiconductor's (NVTS) Investment Narrative?

In April 2026, Navitas Semiconductor advanced its “Navitas 2.0” push into high-power GaN and SiC by unveiling an 800 V–6 V DC-DC power delivery board for NVIDIA data center infrastructure and adding semiconductor veteran Gregory M. Fischer to its board to deepen expertise in AI and high-power markets. These moves highlight how Navitas is trying to align its leadership, technology roadmap, and AI-focused power solutions with emerging data center and high-performance computing demand. We’ll...
NYSE:BW
NYSE:BWElectrical

Babcock And Wilcox Faces Contract Scrutiny And Governance Risks For Investors

Short-seller report challenges the legitimacy of Babcock & Wilcox Enterprises' purported $2.4b contract and raises concerns about undisclosed related-party links. Securities fraud class action lawsuits have been filed, alleging failures in disclosure and questioning the integrity of the company’s contract reporting. These governance and disclosure issues are drawing attention to the risks around large power generation deals and potential impact on shareholder confidence. Babcock & Wilcox...
NYSE:T
NYSE:TTelecom

How Investors May Respond To AT&T (T) Integrating RapidSOS AI Into Its Nationwide ESInet 911 Network

In late April 2026, RapidSOS announced that its HARMONY AI platform is now integrated into AT&T ESInet, bringing real‑time intelligence from more than 723 million connected devices directly into NG911 emergency call routing over AT&T’s private, nationwide 911 IP network. This move deepens AT&T’s role in public safety infrastructure by pairing its widely deployed ESInet and FirstNet backup with AI‑enhanced situational awareness that can travel with 911 calls across agencies and disaster...
NasdaqGS:ACAD
NasdaqGS:ACADBiotechs

Acadia R&D Chief Plans Retirement As Company Stresses Pipeline Continuity

Acadia Pharmaceuticals (NasdaqGS:ACAD) announced the planned retirement of its Head of Research and Development, Dr. Elizabeth H.Z. Thompson. Dr. Thompson is expected to transition from her current role and remain with the company as a consultant through at least the end of 2026. Her consulting role is intended to support continuity around a key Phase 2 clinical readout in Alzheimer's disease psychosis and early Phase 3 planning. Acadia focuses on central nervous system conditions, where...
NYSE:GLOB
NYSE:GLOBIT

Assessing Globant (GLOB) Valuation As Class Action Lawsuits Challenge Its Latin American Pivot

Globant (NYSE:GLOB) is under pressure after multiple law firms launched securities class actions over its Latin American business pivot, raising questions about disclosure practices and coinciding with a sharp share price pullback. See our latest analysis for Globant. Legal headlines and the recent shelf registration have landed on a stock that was already under pressure, with a 30 day share price return of negative 15.11% and a 1 year total shareholder return of negative 66.01%. This points...
NYSE:LION
NYSE:LIONEntertainment

Assessing Lionsgate Studios (LION) Valuation After A Strong Share Price Run

Why Lionsgate Studios is on investors’ radar today Lionsgate Studios (LION) has attracted fresh attention after strong share price moves over the month and past 3 months, prompting investors to reassess what the current US$12.65 level implies for future expectations. See our latest analysis for Lionsgate Studios. The recent move to US$12.65 caps a strong run, with a 31.36% 1 month share price return and 37.05% 3 month share price return, contributing to a 78.36% 1 year total shareholder...
NYSE:HR
NYSE:HRHealth Care REITs

A Look At Healthcare Realty Trust’s Valuation As Raised Guidance Follows Record Leasing And Higher Same-Store NOI

Healthcare Realty Trust (HR) has given investors fresh numbers to consider after a record first quarter, raising full-year FFO and same-store NOI guidance on strong leasing, higher occupancy, solid tenant retention, and active capital moves. See our latest analysis for Healthcare Realty Trust. The recent earnings beat, higher full year guidance, fresh joint venture activity, and a new delayed draw term loan have coincided with a firming share price. A 30 day share price return of 10.63% and a...
NYSE:ZETA
NYSE:ZETASoftware

Is Zeta Global Holdings (ZETA) Attractive After Recent Share Price Strength And DCF Upside Estimate

For investors considering whether Zeta Global Holdings at around US$18.60 is offering value or is priced too richly, this article explores what the current share price may be implying about the business. The stock has moved 6.1% over the last 7 days and 17.8% over the last 30 days. Year to date it is down 6.6%, while it shows a 36.0% return over the past year and a 123.0% return over the last 3 years. Recent coverage on Zeta Global Holdings has focused on its position in the software sector...
NYSE:FIS
NYSE:FISDiversified Financial

A Look At Fidelity National Information Services’ (FIS) Valuation After Recent Share Price Weakness

Why Fidelity National Information Services is on investors’ radar Fidelity National Information Services (FIS) has drawn fresh attention after a weak past 3 months, with the stock showing a roughly 17% negative return and sitting near US$46.54 at the last close. See our latest analysis for Fidelity National Information Services. Short term momentum has steadied slightly, with a positive 7 day share price return and a small 30 day gain, but this comes after a much weaker backdrop, including a...
NasdaqGS:SRPT
NasdaqGS:SRPTBiotechs

Do Sarepta Therapeutics’ (SRPT) Bullish Earnings Forecasts and Vanguard Stake Hint at a Shifting Risk Profile?

In recent days, Sarepta Therapeutics drew attention as Wall Street analysts projected a year-over-year earnings increase despite lower revenues for its upcoming 6 May earnings report, while a Schedule 13G filing showed Vanguard Capital Management holding a 5.11% passive stake. This combination of more bullish earnings expectations and confirmation of meaningful passive institutional ownership highlights how sentiment and ownership structure may be shaping views on Sarepta’s outlook. We’ll...
NasdaqGS:RARE
NasdaqGS:RAREBiotechs

Ultragenyx Pharmaceutical (RARE) Valuation Check After Recent Share Price Momentum And Ongoing Losses

Ultragenyx Pharmaceutical: what recent returns signal for investors Ultragenyx Pharmaceutical (RARE) has drawn attention after a roughly 10% gain over the past month, standing out against a flat past 3 months and a roughly 37% decline over the past year. See our latest analysis for Ultragenyx Pharmaceutical. The recent 10.3% 1 month share price return, alongside a modest 4.9% year to date gain, contrasts with a 37.0% 1 year total shareholder return decline. This suggests short term momentum...